Cargando…

β-cryptoxanthin and fatty liver disease: new insights

Detalles Bibliográficos
Autor principal:	Clugston, Robin D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282678/ https://www.ncbi.nlm.nih.gov/pubmed/37351127 http://dx.doi.org/10.21037/hbsn-23-201

Ejemplares similares

Role of carotenoid β-cryptoxanthin in bone homeostasis
por: Yamaguchi, Masayoshi
Publicado: (2012)

Prevention of Adiposity by the Oral Administration of β-Cryptoxanthin
por: Takayanagi, Katsuhiko
Publicado: (2011)

A hypocaloric high-protein diet supplemented with β-cryptoxanthin improves non-alcoholic fatty liver disease: a randomized controlled trial
por: Haidari, Fatemeh, et al.
Publicado: (2020)

Pathogenesis of Alcohol-Associated Fatty Liver: Lessons From Transgenic Mice
por: Ferdouse, Afroza, et al.
Publicado: (2022)

Combined Ingestion of Tea Catechin and Citrus β-Cryptoxanthin Improves Liver Function via Adipokines in Chronic Obesity
por: Nakadate, Kazuhiko, et al.
Publicado: (2023)

Cancer Chemoprevention by Citrus Pulp and Juices Containing High Amounts of β-Cryptoxanthin and Hesperidin
por: Tanaka, Takuji, et al.
Publicado: (2012)

Preventive effects of β-cryptoxanthin against cadmium-induced oxidative stress in the rat testis
por: Liu, Xiao-Ran, et al.
Publicado: (2016)

Preventive Effects of β-Cryptoxanthin, a Potent Antioxidant and Provitamin A Carotenoid, on Lifestyle-Related Diseases—A Central Focus on Its Effects on Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Nishino, Azusa, et al.
Publicado: (2021)

β-Cryptoxanthin Alleviates Diet-Induced Nonalcoholic Steatohepatitis by Suppressing Inflammatory Gene Expression in Mice
por: Kobori, Masuko, et al.
Publicado: (2014)

β-Cryptoxanthin Reduces Body Fat and Increases Oxidative Stress Response in Caenorhabditis elegans Model
por: Llopis, Silvia, et al.
Publicado: (2019)

Retention of Carotenoids in Biofortified Maize Flour and β-Cryptoxanthin-Enhanced Eggs after Household Cooking
por: Sowa, Margaret, et al.
Publicado: (2017)

Chemoprevention by the Oxygenated Carotenoid β‐Cryptoxanthin of N‐Methylnitrosourea‐induced Colon Carcinogenesis in F344 Rats
por: Narisawa, Tomio, et al.
Publicado: (1999)

Effects of β-Cryptoxanthin on Improvement in Osteoporosis Risk: A Systematic Review and Meta-Analysis of Observational Studies
por: Kim, Sun Jo, et al.
Publicado: (2021)

Development of an HPLC-PDA Method for the Determination of Capsanthin, Zeaxanthin, Lutein, β-Cryptoxanthin and β-Carotene Simultaneously in Chili Peppers and Products
por: Xu, Jiayue, et al.
Publicado: (2023)

Anti-Inflammatory Effects of β-Cryptoxanthin on 5-Fluorouracil-Induced Cytokine Expression in Human Oral Mucosal Keratinocytes
por: Yamanobe, Hironaka, et al.
Publicado: (2023)

Trans-Lycopene and β-Cryptoxanthin Intake and Stomach Cancer in Vietnamese Men: A Pilot Case-Control Study
por: Sengngam, Khanpaseuth, et al.
Publicado: (2022)

Effect of a high-protein diet with β-cryptoxanthin supplementation on metabolic risk factors, oxidative and inflammatory biomarkers in non-alcoholic fatty liver disease (NAFLD): study protocol for a randomized controlled clinical trial
por: Haidari, Fatemeh, et al.
Publicado: (2018)

Editorial: new insights into the relationship between the intestine and non‐alcoholic fatty liver—is “fatty gut” involved in disease progression?
por: Valenti, L., et al.
Publicado: (2017)

Reproducibility and Validity of a Food Frequency Questionnaire to Measure the Consumption of β-Carotene, β-Cryptoxanthin, Folate, Vitamin D, EPA, and DHA
por: Yoshizawa, Kazuko, et al.
Publicado: (2022)

Anti-Obesity and Anti-Inflammatory Synergistic Effects of Green Tea Catechins and Citrus β-Cryptoxanthin Ingestion in Obese Mice
por: Nakadate, Kazuhiko, et al.
Publicado: (2023)

Supplementation of highly concentrated β-cryptoxanthin in a satsuma mandarin beverage improves adipocytokine profiles in obese Japanese women
por: Iwamoto, Masako, et al.
Publicado: (2012)

Growth profiling, kinetics and substrate utilization of low-cost dairy waste for production of β-cryptoxanthin by Kocuria marina DAGII
por: Mitra, Ruchira, et al.
Publicado: (2018)

Different Doses of β-Cryptoxanthin May Secure the Retina from Photooxidative Injury Resulted from Common LED Sources
por: Orhan, Cemal, et al.
Publicado: (2021)

Safety, Tolerability, and Pharmacokinetics of β-Cryptoxanthin Supplementation in Healthy Women: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
por: Tan, Karen M. L., et al.
Publicado: (2023)

Dietary β-Cryptoxanthin and α-Carotene Have Greater Apparent Bioavailability Than β-Carotene in Subjects from Countries with Different Dietary Patterns
por: Olmedilla-Alonso, Begoña, et al.
Publicado: (2020)

β-Cryptoxanthin Improves p62 Accumulation and Muscle Atrophy in the Soleus Muscle of Senescence-Accelerated Mouse-Prone 1 Mice
por: Noguchi, Mari, et al.
Publicado: (2020)

Chemopreventive Effect of β-Cryptoxanthin on Human Cervical Carcinoma (HeLa) Cells Is Modulated through Oxidative Stress-Induced Apoptosis
por: Gansukh, Enkhtaivan, et al.
Publicado: (2019)

Single oral β-cryptoxanthin administration increases its serum concentration and enhances peripheral blood neutrophil function in Holstein cattle
por: KIMURA, Atsushi, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

β-Cryptoxanthin Attenuates Cigarette-Smoke-Induced Lung Lesions in the Absence of Carotenoid Cleavage Enzymes (BCO1/BCO2) in Mice
por: Chiaverelli, Rachel A., et al.
Publicado: (2023)

Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
por: Alam, Shahinul, et al.
Publicado: (2021)

Metabolic-associated fatty liver disease: New nomenclature and approach with hot debate
por: Fouad, Yasser
Publicado: (2023)

Diabetes and Nonalcoholic Fatty Liver Disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Glutamine, fatty liver disease and aging
por: Simón, Jorge, et al.
Publicado: (2021)

Metabolic-associated Fatty Liver Disease
por: Zheng, Ming-Hua
Publicado: (2021)

β-Cryptoxanthin Maintains Mitochondrial Function by Promoting NRF2 Nuclear Translocation to Inhibit Oxidative Stress-Induced Senescence in HK-2 Cells
por: Zhang, Ye, et al.
Publicado: (2023)

Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
por: Jung, Han Na, et al.
Publicado: (2023)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
por: Gu, Weijun, et al.
Publicado: (2022)

Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease
por: Han, Eugene
Publicado: (2022)

Implications of comorbidities in nonalcoholic fatty liver disease
por: Song, Sherlot Juan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vju41hnggbf320h962e762a07l